Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population. (2020)
Attributed to:
Mendelian randomization to hypothesis-free causal inference
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/hep.31238
PubMed Identifier: 32190914
Publication URI: http://europepmc.org/abstract/MED/32190914
Type: Journal Article/Review
Volume: 72
Parent Publication: Hepatology (Baltimore, Md.)
Issue: 3
ISSN: 0270-9139